The quarter included three IPOs worth US$ 428 million and one Qualified Institutional Placement (QIP) worth US$ 88 million
AI-powered cardiometabolic wellness platform for India’s workforce
Everolimus is an mTOR inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in adult patients in kidney and liver transplantation
Novartis India has reported total income of Rs. 99.73 crore during the period ended September 30, 2025
Test delivers results in just 18 minutes, enabling faster laboratory workflows and patient management during outbreaks
New AI capabilities will help scientists identify, optimize, and validate new molecules. Additional applications include manufacturing, medical imaging, and enterprise AI agents
Allergan Aesthetics reaffirms commitment to empowering girls through STEM mentorship and education initiatives
The EIR was issued with an inspection classification of Voluntary Action Indicated (VAI) post the inspection conducted in June 2025
Key secondary endpoints also demonstrated statistically significant and clinically meaningful benefits with Gazyva
Quest Diagnostics’ blood-based test panels demonstrate confirmatory accuracy, potentially reducing the need for PET imaging
Subscribe To Our Newsletter & Stay Updated
